Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-27T02:28:44.236Z Has data issue: false hasContentIssue false
  • English
  • Français

Ziprasidone: In vivo evidence of central 5HT1A agonist activity

Published online by Cambridge University Press:  16 April 2020

H. Rollema ,
J.S. Sprouse ,
Y. Lu ,
L.S. Reynolds ,
J.P. Braselton  and
S.H. Zorn
H. Rollema
Affiliation:
Department for Neuroscience, Pfizer Inc., Groton, CT06340, USA
J.S. Sprouse
Affiliation:
Department for Neuroscience, Pfizer Inc., Groton, CT06340, USA
Y. Lu
Affiliation:
Department for Neuroscience, Pfizer Inc., Groton, CT06340, USA
L.S. Reynolds
Affiliation:
Department for Neuroscience, Pfizer Inc., Groton, CT06340, USA
J.P. Braselton
Affiliation:
Department for Neuroscience, Pfizer Inc., Groton, CT06340, USA
S.H. Zorn
Affiliation:
Department for Neuroscience, Pfizer Inc., Groton, CT06340, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 302s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.